
NATR Stock Forecast & Price Target
NATR Analyst Ratings
Bulls say
Natures Sunshine Products is a promising investment opportunity due to its strong market position and growth potential. The company's diverse product line in the general health, immune, cardiovascular, digestive, personal care, and weight management segments allows for multiple sources of revenue. Despite a recent dip in sales due to disruptions in China, the company's long-term growth prospects remain intact with a clear roadmap for expansion and potential for acquisitions. Furthermore, the company's global operations expose it to certain risks but also provide opportunities for growth and reaching new markets. As competition in the industry increases and consumer preferences evolve, Natures Sunshine is dedicated to staying current and adapting accordingly.
Bears say
Natures Sunshine Products is facing significant challenges to achieve its ambitious Vision for Growth goals due to intense competition in the natural health and wellness industry, potential pushback from regulators on product claims, and the company's unproven track record with M&A. Furthermore, the company's heavy reliance on the Asian market for revenue and uncertain expansion plans may hinder its ability to diversify and mitigate potential risks. This is reflected in the company's lower than average EBITDA margin of 10%, which may make it difficult to achieve the targeted 15% margin in the near future.
This aggregate rating is based on analysts' research of Nature's Sunshine Products and is not a guaranteed prediction by Public.com or investment advice.
NATR Analyst Forecast & Price Prediction
Start investing in NATR
Order type
Buy in
Order amount
Est. shares
0 shares